Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ketones are billed as the alternative energy source in the athletic world. With Tour de France 2019 just round the corner, this week Professor Kieran Clarke features on the Oxford Sparks Big Questions podcast to answer the question: why are professional cyclists using ketones?

kieran.jpgWhen a human body runs out of carbohydrate, ketones are produced by the liver from fat, as an alternative fuel to glucose, which the brain needs to survive. 

Professor Kieran Clarke has been with the Department since 1991, working on the effects of diet on energy metabolism in human heart, brain and skeletal muscle. Professor Clarke’s work has led to the development of a fourth food group, a novel ketone ester, called ΔG®, that improves endurance performance and could be used for the management of human metabolic diseases, such as type 2 diabetes and Alzheimer’s disease.  

The Tour de France, a competition considered to be one of the hardest athletic challenges, is set to start in a few weeks. A Tour de France rider will burn enough calories during a six-hour mountain stage to fuel an average person's activity for two to four days. In light of this, Oxford Sparks invited Professor Clarke to take part in their latest Big Questions podcast asking the question: Why are athletes using ketones?

Click here for the full podcast.

 

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Professor Dame Frances Ashcroft to receive Vanderbilt Prize in Biomedical Science

The Vanderbilt Prize in Biomedical Science recognises women scientists with a stellar record of research accomplishments who also have made significant contributions to mentoring other women in science.

Annie Park to advance our understanding of how the brain encodes reward with new Wellcome Trust Award

Congratulations are in order for Postdoctoral Fellow Dr Annie Park who has been awarded a prestigious Wellcome Early-Career Award.

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.